Results

Total Results: 918 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-disposition-comments.pdf
    November 20, 2024 - KI Reviewer #2 Introduction [pg. 2, "that there is no impact or increased risk to patient safety"]: … (environmental impact - or do you still mean patient safety?) … Many of those factors, including patient safety, can be quantified and compared to the potential human … KI Reviewer #2 Findings [pg. 13, GQ1a, "frameworks included a human health or patient safety component … Peer reviewer #1 Findings Page 19 line 31, LCA is not meant to consider patient safety except in the
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - To date, no comparative effectiveness review comparing the effectiveness and safety of FDA-approved … with chronic plaque psoriasis, what is the comparative safety of systemic biologic agents and systemic … followup), patient baseline characteristics (including whether the patient is naïve to biologic therapy … We will also conduct subgroup analyses based on the patient population evaluated, including patients … Efficacy and safety results from the randomized controlled comparative study of adalimumab vs.
  3. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
    January 01, 2020 - Experts wanted to see additional clinical trial data assessing baclofen’s long-term safety and efficacy … Additionally, safety reporting from a bioavailability study in healthy volunteers noted similar adverse … All adult volunteers, and 15 of 19 adolescent volunteers were able to successfully remove the safety … The devices are not intended for laypersons and do not appear to have the audible instructions, LED indicators … or increased risk of opioid overdose.45 Overall, experts noted that because of Evzio’s extensive safety
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
    July 01, 2012 - How were previously established prognostic indicators or other prognostic assessments included in the … Were any previously established prognostic indicators or prediction models being used as comparators … Reviewers need to be aware of any previously established prognostic indicators that should be included … • A large number of published reports focus on the associations between prognostic indicators and … Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
    January 01, 2018 - researchers, health care providers, informaticians and technologists, app developers, as well as patient … We plan to have a separate call for patient/caregiver KI at the start of the project, with questions … /clients and health care providers; security and privacy features such as data usage and sharing of … Key substance use and mental health indicators in the United States: Results from the 2019 National … how it works, how it is currently used or might be used, and which features may be important from a patient
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
    May 01, 2012 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … , 10 diagnostic groups for hospital discharges, 10 diagnostic groups for outpatient visits, and 10 indicators … A common question in pharmacoepidemiologic studies of drug safety is whether the risk conferred by a … Pharmacoepidemiology and Drug Safety 2008;17:546-555. … Pharmacoepidemiol Drug Safety 2005;14(7):465-76.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
    October 01, 2011 - Yes – pg. 404, Table 1. of the Goldstein 2010 publication shows that the patient demographics and baseline … Was the patient blinded? … Yes – pg. 404, Table 1. of the Goldstein 2010 publication shows that the patient demographics and baseline … Was the patient blinded? … The end results of question four reinforced the need for each patient to be treated based on their
  8. Ced -Appendix-2 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    May 29, 2025 - AHRQ revise the study design CED recommendation to provide patients more ethical and equitable coverage … KIs should have also represented life sciences industries, patients, and underrepresented populations … use of CED for on-label uses of drugs and biologics that have gone through FDA evaluation process for safety … use of CED for on-label uses of drugs and biologics that have gone through FDA evaluation process for safety … AHRQ revise the study design CED recommendation to provide patients more ethical and equitable coverage
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-iv-patient-safety-practices-year-2.pdf
    May 01, 2025 - Director, General Patient Safety Program Center for Quality Improvement and Patient Safety Agency … Patients for Patient Safety, U.S. … safety practices for responding to harms experienced by patients during clinical care (N=8) ....... … safety outcomes • Programs for responding to harms experienced by patients during clinical care … safety practices for responding to harms experienced by patients during clinical care (N=8)
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
    September 01, 2011 - and systematic, even encyclopedic, compilation of information on treatment patterns, efficacy, and safetyPatient heterogenity is an issue in most of our analyses. … Pharmacoepidemiology and drug safety (2011) DOI: 10.1002/pds.2082 The study results indicated 75% … The accessibility of patient information is critically important. … Effects of extended release quetiapine fumarate (Quetiapine XR) on patient-reported outcomes in patients
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
    April 01, 2010 - Instrumental variable methods in comparative safety and effectiveness research. … Similarly, one could assess safety in these same patients by exploring the association between formulary … In some cases, the concept of a “marginal patient” may be problematic as individual patients may be … Distance must also not be related to patient characteristics. … first-stage regression, in particular the partial r-squared value and the first-stage F statistic, both indicators
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - There is clinical uncertainty about the optimal choice of VTE prophylaxis in this patient population … This CER will evaluate the comparative effectiveness and safety of pharmacologic prophylaxis among patients … What is the comparative effectiveness and safety of IVC filters to prevent PE in hospitalized patients … and individual patient risk factors. … Deep-vein thrombosis: advancing awareness to protect patient lives.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
    October 01, 2008 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … and we are evaluating the safety of tumor necrosis factor alpha (TNF-α) antagonists in a cohort of … patients with rheumatoid arthritis (RA). … fraction of 65% without further details and 1 had a report indicating normal ventricular function in a patient … with RA and could be used in assessments of medication safety.
  14. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - surgery, but choose to decline due to safety concerns. … for similar reasons, but mentioned long-term safety to be a concern. … health, many expressed concerns regarding long-term safety and efficacy. … data and postmarket safety evaluation—set forth by FDA. … potential impact on patient health.
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - This report evaluates the level of evidence currently available to support the effectiveness and safety … The FDA drug approval process mandates randomized clinical trials that demonstrate efficacy and safety … Use of rFVIIa for selected indications in patient with/undergoing cardiac surgery Key Question 4c. … • Are there patient subpopulations more likely to benefit from rFVIIa use? … • Are there patient subpopulations where harms are more likely?
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - A disadvantage of this over individual patient randomization is that outcomes for patients from a … A disadvantage of this over individual patient randomization is that outcomes for patients from a … post-ASCR EFS 1 patient died of toxicity at 3 months follow up. 5 patients were DOD at 5- 21 months … (70%), partial remission in 1 patient (2%) and stable disease in 13 patients (28%). … with high-risk solid tumors Safety/Efficacy study 30 patients (up to 30 years of age) 6/2006
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0576-150420.pdf
    December 10, 2014 - Outcome(s): Restraint and seclusion rates; staff and patient injuries; cost and resource utilization … inpatient psychiatric setting to manage aggressive behavior of a person that may impact their own safety … or the safety of others, including staff. … The challenge is to identify a standard of practice that ensures safety while maintaining patients’ … because of high interest from potential stakeholder groups in this topic, particularly related to safety
  18. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - This, in turn, may affect the perceived effectiveness or safety of the product if the registry does … Drug Safety. 2015 January 1;38(1):13-5. 4. Elger B, Biller-Andorno N, Mauron A, et al. … http://www.fda.gov/downloads/Drugs/Drug Safety/ucm089809.pdf. Accessed January 10, 2017. 21. … Direct-to-patient research: piloting a new approach to understanding drug safety during pregnancy. … Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
    December 14, 2017 - Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma. … Safety and feasibility of bronchial thermoplasty in asthma patients with very severe fixed airflow … Safety and Feasibility of Bronchial Thermoplasty in Asthma Patients with Very Severe Fixed Airflow … PAS2 study patients treated with BT showed procedural safety and clinical improvements during each of … , no information is available regarding BT’s safety and efficacy in a broader population of patients
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
    August 01, 2015 - Patient Stakeholder Baltimore, MD Ruth Horowitz, M.D. … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Endpoint Classification: Safety Study Intervention Model: Single Group Assignment … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: